Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 3.80% and Operating profit at -9.92% over the last 5 years
- RAW MATERIAL COST(Y) Grown by 9.42% (YoY)
- NET SALES(Q) Lowest at CNY 112.8 MM
- OPERATING PROFIT(Q) Lowest at CNY 10.99 MM
2
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,854 Million (Small Cap)
26.00
NA
2.59%
-0.50
5.76%
1.49
Revenue and Profits:
Net Sales:
113 Million
(Quarterly Results - Mar 2026)
Net Profit:
10 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.24%
0%
-18.24%
6 Months
-23.55%
0%
-23.55%
1 Year
-19.59%
0%
-19.59%
2 Years
-8.18%
0%
-8.18%
3 Years
-51.87%
0%
-51.87%
4 Years
-4.78%
0%
-4.78%
5 Years
-37.73%
0%
-37.73%
Ningbo David Medical Device Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.80%
EBIT Growth (5y)
-9.92%
EBIT to Interest (avg)
87.47
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.47
Tax Ratio
5.38%
Dividend Payout Ratio
26.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.37%
ROE (avg)
9.85%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.49
EV to EBIT
20.02
EV to EBITDA
14.84
EV to Capital Employed
1.98
EV to Sales
2.14
PEG Ratio
0.36
Dividend Yield
2.59%
ROCE (Latest)
9.91%
ROE (Latest)
5.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
112.80
121.20
-6.93%
Operating Profit (PBDIT) excl Other Income
11.00
24.40
-54.92%
Interest
0.10
0.40
-75.00%
Exceptional Items
1.40
0.00
Consolidate Net Profit
9.90
22.60
-56.19%
Operating Profit Margin (Excl OI)
97.40%
147.50%
-5.01%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -6.93% vs -21.96% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -56.19% vs -40.68% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
580.50
524.50
10.68%
Operating Profit (PBDIT) excl Other Income
99.60
86.50
15.14%
Interest
0.90
0.90
Exceptional Items
2.00
0.20
900.00%
Consolidate Net Profit
87.10
57.30
52.01%
Operating Profit Margin (Excl OI)
120.70%
113.00%
0.77%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.68% vs -14.47% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 52.01% vs -61.18% in Dec 2024
About Ningbo David Medical Device Co., Ltd. 
Ningbo David Medical Device Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






